French consensus on management of head and neck cancer surgery during COVID-19 pandemic.
Betacoronavirus
/ isolation & purification
COVID-19
Consensus
Coronavirus Infections
/ diagnosis
France
/ epidemiology
Head and Neck Neoplasms
/ surgery
Humans
Pandemics
/ prevention & control
Pneumonia, Viral
/ diagnosis
SARS-CoV-2
Squamous Cell Carcinoma of Head and Neck
/ surgery
Surgical Oncology
/ methods
Tracheostomy
/ methods
COVID
COVID-19
ENT
Head and neck cancer
SARS-Cov-2
Journal
European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465
Informations de publication
Date de publication:
May 2020
May 2020
Historique:
pubmed:
19
4
2020
medline:
23
5
2020
entrez:
19
4
2020
Statut:
ppublish
Résumé
In the context of the current pandemic, there is a need for specific advice concerning treatment of patients with Head and Neck cancers. The rule is to limit as much as possible the number of patients in order to reduce the risks of contamination by the SARS-Cov-2 virus for both patients and the caregivers, who are particularly exposed in ENT. The aim is to minimize the risk of loss of opportunity for patients and to anticipate the increased number of cancer patients to be treated at the end of the pandemic, taking into account the degree of urgency, the difficulty of the surgery, the risk of contaminating the caregivers (tracheotomy) and the local situation (whether or not the hospital and intensive care departments are overstretched).
Identifiants
pubmed: 32303485
pii: S1879-7296(20)30098-3
doi: 10.1016/j.anorl.2020.04.008
pmc: PMC7151337
pii:
doi:
Types de publication
Practice Guideline
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
159-160Informations de copyright
Copyright © 2020 Elsevier Masson SAS. All rights reserved.
Références
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238